Epithelial ovarian cancer: Focus on targeted therapy

Journal of Oncology

Volumn , Issue , 2010, Pages

  Markman, M ^a   Sehouli, Jalid ^b   Levenback, Charles F ^a   Chi, Dennis S ^c  

^a UNIVERSITY OF TEXAS   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; EPIDERMAL GROWTH FACTOR; GLUCOSE; HISTONE DEACETYLASE; INSULIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;

ANTIANGIOGENIC THERAPY; CANCER IMMUNOTHERAPY; CYTOREDUCTIVE SURGERY; EDITORIAL; EPITHELIAL OVARIAN CANCER; EPITHELIUM TUMOR; METASTASIS; OVARY CANCER; PERSONALIZED MEDICINE;

EID: 80052667563     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2010/171425     Document Type: Editorial

References (1)

1. Hennessy B. T., Coleman R. L., Markman M., Ovarian cancer The Lancet 2009 374 1371 1382